Cost-utility of adjuvant hormone therapies for breast cancer in post-menopausal women: sequential tamoxifen-exemestane and upfront anastrozole

被引：0
|
作者：
C. Skedgel
D. Rayson
R. Dewar
T. Younis
机构：
[1] Dalhousie University,Department of Medicine, Centre for Clinical Research
[2] Cancer Care Nova Scotia,undefined
来源：
Breast Cancer Research and Treatment | 2007年 / 101卷
关键词：
Adjuvant hormonal therapy; Anastrozole; Aromatase inhibitors; Breast cancer; Cost-utility analysis; Exemestane; Tamoxifen;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：325 / 333
页数：8
相关论文
共 50 条
  • [1] Cost-utility of adjuvant hormone therapies for breast cancer in post-menopausal women: sequential tamoxifen-exemestane and upfront anastrozole
    Skedgel, C.
    Rayson, D.
    Dewar, R.
    Younis, T.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 101 (03) : 325 - 333
  • [2] Cost-utility of adjuvant hormone therapies with aromatase inhibitors in post-menopausal women with breast cancer: Upfront anastrozole, sequential tamoxifen-exemestane and extended tamoxifen-letrozole
    Skedgel, C.
    Rayson, D.
    Dewar, R.
    Younis, T.
    BREAST, 2007, 16 (03): : 252 - 261
  • [3] Cost Effectiveness of Exemestane versus Tamoxifen in Post-Menopausal Women with Early Breast Cancer in Germany
    Braun, Sebastian
    Mittendorf, Thomas
    Menschik, Thomas
    Greiner, Wolfgang
    von der Schulenburg, Johann-Matthias
    BREAST CARE, 2009, 4 (06) : 389 - 396
  • [4] The effect of anastrozole on the pharmacokinetics of tamoxifen in post-menopausal women with early breast cancer
    M Dowsett
    J S Tobias
    A Howell
    G M Blackman
    H Welch
    N King
    R Ponzone
    M von Euler
    M Baum
    British Journal of Cancer, 1999, 79 : 311 - 315
  • [5] The effect of anastrozole on the pharmacokinetics of tamoxifen in post-menopausal women with early breast cancer
    Dowsett, M
    Tobias, JS
    Howell, A
    Blackman, GM
    Welch, H
    King, N
    Ponzone, R
    von Euler, M
    Baum, M
    BRITISH JOURNAL OF CANCER, 1999, 79 (02) : 311 - 315
  • [6] Cost-effectiveness of exemestane vs. tamoxifen in post-menopausal women with early breast cancer in Germany
    Braun, S.
    Mittendorf, T.
    Greiner, W.
    Dopatka, J.
    von der Schulenburg, J. M.
    VALUE IN HEALTH, 2007, 10 (06) : A326 - A326
  • [7] Exemestane for Chemoprevention of Breast Cancer in post-menopausal Women
    Richter-Ehrenstein, C.
    ONKOLOGE, 2011, 17 (09): : 834 - +
  • [8] A randomized trial exploring the biomarker effects of neoadjuvant sequential treatment with exemestane and anastrozole in post-menopausal women with hormone receptor-positive breast cancer
    Freedman, O. C.
    Amir, E.
    Hanna, W.
    Kahn, H.
    O'Malley, F.
    Dranitsaris, G.
    Cole, D. E. C.
    Verma, S.
    Folkerd, E.
    Dowsett, M.
    Clemons, M.
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 119 (01) : 155 - 161
  • [9] A randomized trial exploring the biomarker effects of neoadjuvant sequential treatment with exemestane and anastrozole in post-menopausal women with hormone receptor-positive breast cancer
    O. C. Freedman
    E. Amir
    W. Hanna
    H. Kahn
    F. O’Malley
    G. Dranitsaris
    D. E. C. Cole
    S. Verma
    E. Folkerd
    M. Dowsett
    M. Clemons
    Breast Cancer Research and Treatment, 2010, 119 : 155 - 161
  • [10] Anastrozole Use in Early Stage Breast Cancer of Post-Menopausal Women
    Milani, Monica
    Jha, Gautam
    Potter, David A.
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 141 - 156
12345